Page 123 - 80_01

Class
I
phosphoinositide
3-­-kinases
in
immunity…

108.
Bartok,
B.;
Boyle,
D.
L.;
Liu,
Y.;
Ren,
P.;
Ball,
S.
T.;
Bugbee,
W.
D.;
Rommel,
C.;
&
al.
PI3

kinase
d
is
a
key
regulator
of
synoviocyte
function
in
rheumatoid
arthritis.
Amer
J
Pathol

180,
1906-­-1916
(2012).

109.
Vinuesa,
C.
G.;
Cook,
M.
C.;
Angelucci,
C.;
Athanasopoulos,
V.;
Rui,
L.;
Hill,
K.
M.;
Yu,
D.;
&
al.

A
RING-­-type
ubiquitin
ligase
family
member
required
to
repress
follicular
helper
T
cells

and
autoimmunity.
Nature
435,
452-­-458
(2005).

110.
Yu,
D.;
Tan,
A.
H.-­-M.;
Hu,
X.;
Athanasopoulos,
V.;
Simpson,
N.;
Silva,
D.
G.;
Hutloff,
A.;
&
al.

Roquin
represses
autoimmunity
by
limiting
inducible
T-­-cell
co-­-stimulator
messenger
RNA.

Nature
450,
299-­-303
(2007).

111.
Lee,
S.
K.;
Silva,
Diego
G.;
Martin,
Jaime
L.;
Pratama,
A.;
Hu,
X.;
Chang,
P.-­-P.;
Walters,
G.;
&

al.
Interferon-­-?
excess
leads
to
pathogenic
accumulation
of
follicular
helper
T
cells
and

germinal
centers.
Immunity
37,
880-­-892
(2012).

112.
Sweet,
R.
A.;
Lee,
S.
K.;
&
Vinuesa,
C.
G.
Developing
connections
amongst
key
cytokines
and

dysregulated
germinal
centers
in
autoimmunity.
Curr
Opin
Immunol
24,
658-­-664
(2012).

113.
Barber,
D.
F.;
Bartolome,
A.;
Hernandez,
C.;
Flores,
J.
M.;
Redondo,
C.;
Fernandez-­-Arias,
C.;

Camps,
M.;
&
al.
PI3Kg
inhibition
blocks
glomerulonephritis
and
extends
lifespan
in
a

mouse
model
of
systemic
lupus.
Nat
Medicine
11,
933-­-935
(2005).

114.
Barber,
D.
F.;
Bartolome,
A.;
Hernandez,
C.;
Flores,
J.
M.;
Fernandez-­-Arias,
C.;
Rodriguez-­-
Borlado,
L.;
Hirsch,
E.;
&
al.
Class
IB-­-phosphatidylinositol
3-­-kinase
(PI3K)
deficiency

ameliorates
IA-­-PI3K-­-induced
systemic
lupus
but
not
T
cell
invasion.
J
Immunol
176,
589-­-
593
(2006).

115.
Suárez-­-Fueyo,
A.;
Barber,
D.
F.;
Martínez-­-Ara,
J.;
Zea-­-Mendoza,
A.
C.;
&
Carrera,
A.
C.

Enhanced
phosphoinositide
3-­-kinase
d
activity
is
a
frequent
event
in
Systemic
Lupus

Erythematosus
that
confers
resistance
to
activation-­-induced
T
cell
death.
J
Immunol
187,

2376-­-2385
(2011).

116.
Maxwell,
M.
J.;
Tsantikos,
E.;
Kong,
A.
M.;
Vanhaesebroeck,
B.;
Tarlinton,
D.
M.;
&
Hibbs,
M.

L.
Attenuation
of
phosphoinositide
3-­-kinase
d signaling
restrains
autoimmune
disease.
J

Autoimmun
38,
381-­-391
(2012).

117.
Acosta,
Y.
Y.;
Montes-­-Casado,
M.;
Aragoneses-­-Fenoll,
L.;
Dianzani,
U.;
Portolés,
P.;
&
Rojo,
J.

M.
Suppression
of
CD4+
T
lymphocyte
activation
“in
vitro”
and
experimental

encephalomyelitis
“in
vivo”
by
the
phosphatidyl
inositol
3-­-kinase
inhibitor
PIK-­-75.
Int
J

Immunopathol
Pharmacol
MS
1814,
(Enviado)
(2013).

118.
Dagia,
N.
M.;
Agarwal,
G.;
Kamath,
D.
V.;
Chetrapal-­-Kunwar,
A.;
Gupte,
R.
D.;
Jadhav,
M.
G.;

Dadarkar,
S.
S.;
&
al.
A
preferential
p110a/?
PI3K
inhibitor
attenuates
experimental

inflammation
by
suppressing
the
production
of
proinflammatory
mediators
in
a
NF-­-?B-­-
dependent
manner.
Am
J
Physiol
Cell
Physiol
298,
C929-­-941
(2010).

119.
Roller,
A.;
Perino,
A.;
Dapavo,
P.;
Soro,
E.;
Okkenhaug,
K.;
Hirsch,
E.;
&
Ji,
H.
Blockade
of

phosphatidylinositol
3-­-kinase
(PI3K)d
or
PI3K?
reduces
IL-­-17
and
ameliorates

Imiquimod-­-induced
psoriasis-­-like
dermatitis
J
Immunol
189,
4612-­-4620
(2012).

120.
Schreiber,
R.
D.;
Old,
L.
J.;
&
Smyth,
M.
J.
Cancer
immunoediting:
Integrating
immunity's

roles
in
cancer
suppression
and
promotion.
Science
331,
1565-­-1570
(2011).

121.
Vesely,
M.
D.;
Kershaw,
M.
H.;
Schreiber,
R.
D.;
&
Smyth,
M.
J.
Natural
innate
and
adaptive

immunity
to
cancer.
Annu
Rev
Immunol
29,
235-­-271
(2011).

122.
Zou,
W.;
&
Chen,
L.
Inhibitory
B7-­-family
molecules
in
the
tumour
microenvironment.
Nat

Rev
Immunol
8,
467-­-477
(2008).

123.
Strauss,
L.;
Bergmann,
C.;
Szczepanski,
M.
J.;
Lang,
S.;
Kirkwood,
J.
M.;
&
Whiteside,
T.
L.

Expression
of
ICOS
on
human
melanoma-­-infiltrating
CD4+CD25highFoxp3+
T
regulatory

cells:
Implications
and
impact
on
tumor-­-mediated
immune
suppression.
J
Immunol
180,

2967-­-2980
(2008).

124.
Chen,
X.
L.;
Cao,
X.
D.;
Kang,
A.
J.;
Wang,
K.
M.;
Su,
B.
S.;
&
Wang,
Y.
L.
In
situ
expression
and

significance
of
B7
costimulatory
molecules
within
tissues
of
human
gastric
carcinoma.

World
J
Gastroenterol
9,
1370-­-1373
(2003).

125.
Martin-­-Orozco,
N.;
Li,
Y.;
Wang,
Y.;
Liu,
S.;
Hwu,
P.;
Liu,
Y.-­-J.;
Dong,
C.;
&
al.
Melanoma
cells

express
ICOS
ligand
to
promote
the
activation
and
expansion
of
T-­-regulatory
cells.
Cancer

Res
70,
9581-­-9590
(2010).

126.
Conrad,
C.;
&
Gilliet,
M.
Plasmacytoid
dendritic
cells
and
regulatory
T
cells
in
the
tumor

microenvironment:
A
dangerous
liaison.
Oncoimmunology
2,
e23887
(2013).

121